Keep up to date with the latest news and articles from Arthritis Research & Therapy and BioMed Central.
Research article
Clinical significance of antibodies to Ro52/TRIM21 in systemic sclerosis
Marie Hudson*, Janet Pope, Michael Mahler, Solène Tatibouet, Russell Steele, Murray Baron, Canadian Scleroderma Research Group (CSRG) and Marvin J Fritzler